(Q50864371)

24 March 2018

title

Fisetin protects against hepatosteatosis in mice by inhibiting miR-378. (English)

1 reference

24 March 2018

1 reference

Tae-Il Jeon

1

1 reference

24 March 2018

Jin Wook Park

2

1 reference

24 March 2018

Jiyun Ahn

3

1 reference

24 March 2018

Chang Hwa Jung

4

1 reference

24 March 2018

Tae Youl Ha

5

1 reference

24 March 2018

publication date

1 July 2013

1 reference

24 March 2018

Molecular Nutrition and Food Research

published in

1 reference

24 March 2018

volume

57

1 reference

24 March 2018

issue

11

1 reference

24 March 2018

page(s)

1931-1937

1 reference

24 March 2018

Lipid homeostasis, lipotoxicity and the metabolic syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Flavonoids and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Resveratrol and prostate cancer: promising role for microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Metabolic control through the PGC-1 family of transcription coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Transcriptional integration of mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Fatty liver and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Pervasive roles of microRNAs in cardiovascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300071

21 January 2018

Identifiers

DOI

10.1002/MNFR.201300071

1 reference

24 March 2018

1 reference

24 March 2018